$KZR is a Biotech in its own bull market$KZR is a Biotech with 99 RS that is setting up.
Focus list for next week.
Look at how the indices are on the verge of breaking down and where this stock is.
Its in a bull market of its own.
−1.2120USD
−68.239MUSD
58.231M
About Kezar Life Sciences, Inc.
Sector
Industry
CEO
Christopher J. Kirk
Website
Headquarters
South San Francisco
Employees (FY)
84
Founded
2015
ISIN
US49372L1008
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
$KZR Long term PT 35 and higherKezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoprotea
Geesh another kind of penny stock i cant avoidThis stock has a recent increase in institutional transactions of 128%. With Inst. ownership of ~ 43%.
Moving average price following looks prime too.
Like i said before, Not a big penny stock guy... just an opportunity guy.
"KZR" definitely to buy and hold !!!"KZR" is going up for the next coming weeks. It's definitely the moment to buy and hold this stock.
KZR Fib Retracement: Next Target $5 + Big PotentialPlease keep in mind not to take anything I say seriously, as this is of opinion basis and not face value. That being said, let us get to the analysis. I believe through the Fibonacci retracement, we can look at a short target of $5 for the next trend analysis goal of Kezar life sciences. Kezar had a
KZR - Bullish Divergence Found. Possible Change In MomentumKezar Life Sciences, Inc. is a clinical-stage biotechnology company, which discovers and develops novel small molecule therapeutics to treat autoimmunity and cancer. The firm specializes in the areas of protein degradation and protein secretion to discover & develop novel therapies for the treatment
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
